We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Roche Constructs Diagnostics Facility Near Munich

By LabMedica International staff writers
Posted on 06 Oct 2008
Roche (Basel, Switzerland) is investing US$190 million at its site in Penzberg, near Munich, Germany. More...
The money will be used to construct a multi-purpose building for Roche Diagnostics. The new building will be known as the Diagnostics Operations Complex (DOC) and will have a total floor area of 30,400 square meters. The complex consists of a central six-storied laboratory building with a basement flanked by two single-storied factory halls for the production units.

The building will house laboratories and production facilities for the Roche Applied Science and Roche Professional Diagnostics business areas. From about the middle of 2010, the complex will be manufacturing products ranging from biotech constituents for immunodiagnostics and the life-science market through to complete immunodiagnostic test kits. These test kits are used worldwide in diagnostic systems such as Cobas and Elecsys.

One of Roche's important markets is immunodiagnostics, which includes heterogeneous tests such as the cardiac markers NT-proBNP for acute and chronic heart failure and troponin T for myocardial infarction. Roche's immunologic tests are used by physicians for a variety of other applications, such as checking thyroid function, determining tumor markers, detecting infectious diseases such as hepatitis and human immunodeficiency virus (HIV), or helping to verify the effectiveness of drug-based therapy.

"In recent years, we have been successful in continuously expanding and marketing our range of immunodiagnostic tests,” said Jürgen Schwiezer, CEO of Roche's Diagnostics Division. "We are systematically pushing forward our activities in this interesting growth market by strengthening our capacity and capabilities in the research, development, and production of diagnostics constituents and tests. Against this background, the investment marks an important step in enhancing our leading position in the immunodiagnostics segment.”

Roche is an innovator of products and services for the prevention, early detection, diagnosis, and treatment of diseases. Roche is a world leader in in-vitro diagnostics and drugs for cancer and transplantation, and a market leader in virology.

Related Links:
Roche


Gold Member
Troponin T QC
Troponin T Quality Control
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
New
Whole Blood Control
Lyphochek Whole Blood Control
New
UHF RFID Tag & Inlay
AD-327 U9 ETSI Pure 95
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: ctDNA analysis has proved effective in monitoring tumor evolution and resistance mechanisms in real time (Photo courtesy of 123RF)

Genetic Testing and Blood-Based Monitoring Improve Understanding and Tracking of Prostate Cancer

Many men with aggressive prostate cancer face high recurrence rates despite undergoing treatment. Now, findings of a new study suggest that specific gene mutations may be key to understanding these outcomes... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: Custom hardware and software for the real-time detection of immune cell biophysical signatures in NICU (Photo courtesy of Pediatric Research, DOI:10.1038/s41390-025-03952-y)

First-Of-Its-Kind Device Profiles Newborns' Immune Function Using Single Blood Drop

Premature infants are highly susceptible to severe and life-threatening conditions, such as sepsis and necrotizing enterocolitis (NEC). Newborn sepsis, which is a bloodstream infection occurring in the... Read more

Pathology

view channel
Image: An algorithm within the Check4 platform interprets data from the cartridge and sends test results to users by text or email (Photo courtesy of IdentifySensors)

Digital Diagnostic Platform Uses Electronic Technology for Rapid Disease Detection

Traditional diagnostic methods often fall short in providing rapid, accurate detection of infectious diseases, leading to delays in treatment and increased transmission. Now, a groundbreaking digital diagnostics... Read more

Technology

view channel
Image: The second-generation sampler currently under development (Photo courtesy of Breathe BioMedical)

Breath Test to Enable Early Detection of Breast Cancer

Mammograms often fail to detect breast cancer in women with dense breast tissue, missing up to 60% of cases due to reduced image clarity. Breath analytics has the potential to allow for timely detection... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.